Understanding Microorganisms in UTI Diagnostics

We’re incredibly proud to see SepsiSTAT® featured in the World Health Organization’s 2025 report as a developing diagnostic for the ‘isolation and separation of bacteria directly from blood.’ Reporting: ‘Momentum Bioscience’s extraction and enrichment technology enables a simple, blood culture–free workflow for rapid antimicrobial susceptibility testing (AST).’ This recognition underscores the importance of rapid diagnostics in tackling antimicrobial resistance and improving outcomes for patients with sepsis. You can read it here: https://lnkd.in/eCCqwf_b Image courtesy of Milton Park (Oxfordshire) #SepsiSTAT #MomentumBioscience #AntimicrobialResistance #RapidDiagnostics #Sepsis #BloodstreamInfections Sumi Thaker

Xu et al. present an innovative study exploring the role of angiography-derived radial wall strain (RWS) in patients undergoing drug-coated balloon (DCB) angioplasty for small vessel disease. 🔹 Higher RWS values identified vulnerable lesions prone to restenosis 🔹 RWS may serve as a novel marker to guide DCB treatment optimisation This work highlighted how functional vessel mechanics can refine risk assessment and improve outcomes in contemporary PCI practice. Read more: https://lnkd.in/dJ4Ae78y Junbo Ge

🗨️ "...Wakazono and colleagues' study introduces a novel CT-derived measurement of whole lung airway-vessel volume mismatch that may complement visual assessment of bronchiectasis, and perhaps provide insight into a distinct COPD phenotype. The intrigue regarding the airway-vessel volume mismatch lies in its potential to reflect airway-vasculature interactions that may influence lung function." ➡️ Read the full EDITORIAL by Anusha A. Mappanasingam and Sarah Svenningsen, Ph.D. here: https://lnkd.in/gQXtGyeW

#HighlyCited 📑The Role of Coagulase-Negative Staphylococci Biofilms on Late-Onset Sepsis: Current Challenges and Emerging Diagnostics and Therapies 📝by Angela França from Universidade do Minho 🔗 You can read it at: https://lnkd.in/gRrGZRTh

🌍 The World Health Organization has just released its 2025 Landscape Report on diagnostics for bacterial priority pathogens — a detailed look at where the world stands in the fight against antimicrobial resistance. The report maps a wide range of available and pipeline tools for detecting and testing bacterial infections, highlighting both innovation and the gaps that still hold global healthcare systems back. 🔍 One key takeaway: despite technological progress, there remains an urgent need for faster, more accessible phenotypic AST systems — especially those that can move testing closer to the point of care. That’s the mission driving us at Gradientech. Our QuickMIC® system, featured in the report, delivers ultra-rapid AST results in 2–4 hours, providing linear MIC precision to help bridge the gap between diagnostic speed and treatment accuracy. 🤝 We’re delighted to be featured alongside other brilliant innovators working to make diagnostics faster, smarter, and more accessible for patients everywhere. 💪 Reports like this are a powerful reminder of how much progress has been made but also how much work still lies ahead to make rapid AST available everywhere it’s needed. 📘 Read the WHO report: https://lnkd.in/eCCqwf_b #AntimicrobialResistance #AMR #Innovation #WHO #Diagnostics #PrecisionDiagnostics #Sepsis #GlobalHealth

🧠 When your work shapes the discussion at #IDWeek2025 Proud to see HMS work cited in a talk exploring diagnostic uncertainty in pneumonia and the evidence behind routine empiric coverage for atypical pathogens. Studies by Gupta A et al. (BMJ Quality & Safety, 2023; JAMA Internal Medicine, 2024) provided critical insight into the uncertainty surrounding community-acquired pneumonia (CAP)—insights that helped inform the discussion on antibiotic prescribing decisions. Impact isn’t always on the main stage—sometimes it’s in the evidence base shaping how clinicians think. #AntibioticStewardship #DiagnosticStewardship

Although sepsis impacts all countries around the world, low- and middle-income countries bear the largest burden*. Automating laboratory processes such as blood culture can help reduce time to results, supporting timely and effective management of sepsis. bioMérieux makes automation easy and accessible, with solutions designed to meet the needs of labs of different sizes and resources: 🩸 BACT/ALERT® 3D – Offers automated blood culture for labs of any size 🧫 PREVI® COLOR GRAM – For automated Gram staining 🦠 VITEK® COMPACT PRO – Provides fast and reliable identification and susceptibility (ID & AST) testing 🖥️ MAESTRIA™ – Middleware integrates blood culture, Gram staining, identification and antimicrobial susceptibility testing results Explore the bioMérieux Integrated Sepsis Solution: https://lnkd.in/dZKaeNNR #OptimizeDiagnostics #SepsisManagement *World Health Organization, 2024. Product availability varies by country. Please consult your local bioMérieux representative for product availability in your country.

Although sepsis impacts all countries around the world, low- and middle-income countries bear the largest burden*. Automating laboratory processes such as blood culture can help reduce time to results, supporting timely and effective management of sepsis. bioMérieux makes automation easy and accessible, with solutions designed to meet the needs of labs of different sizes and resources: 🩸 BACT/ALERT® 3D – Offers automated blood culture for labs of any size 🧫 PREVI® COLOR GRAM – For automated Gram staining 🦠 VITEK® COMPACT PRO – Provides fast and reliable identification and susceptibility (ID & AST) testing 🖥️ MAESTRIA™ – Middleware integrates blood culture, Gram staining, identification and antimicrobial susceptibility testing results Explore the bioMérieux Integrated Sepsis Solution: https://lnkd.in/eFdn9Afg #OptimizeDiagnostics #SepsisManagement *World Health Organization, 2024. Product availability varies by country. Please consult your local bioMérieux representative for product availability in your country.

Although sepsis impacts all countries around the world, low- and middle-income countries bear the largest burden*. Automating laboratory processes such as blood culture can help reduce time to results, supporting timely and effective management of sepsis. bioMérieux makes automation easy and accessible, with solutions designed to meet the needs of labs of different sizes and resources: 🩸 BACT/ALERT® 3D – Offers automated blood culture for labs of any size 🧫 PREVI® COLOR GRAM – For automated Gram staining 🦠 VITEK® COMPACT PRO – Provides fast and reliable identification and susceptibility (ID & AST) testing 🖥️ MAESTRIA™ – Middleware integrates blood culture, Gram staining, identification and antimicrobial susceptibility testing results Explore the bioMérieux Integrated Sepsis Solution: https://lnkd.in/drqs7ksb #OptimizeDiagnostics #SepsisManagement *World Health Organization, 2024. Product availability varies by country. Please consult your local bioMérieux representative for product availability in your country.

Although sepsis impacts all countries around the world, low- and middle-income countries bear the largest burden*. Automating laboratory processes such as blood culture can help reduce time to results, supporting timely and effective management of sepsis. bioMérieux makes automation easy and accessible, with solutions designed to meet the needs of labs of different sizes and resources: 🩸 BACT/ALERT® 3D – Offers automated blood culture for labs of any size 🧫 PREVI® COLOR GRAM – For automated Gram staining 🦠 VITEK® COMPACT PRO – Provides fast and reliable identification and susceptibility (ID & AST) testing 🖥️ MAESTRIA™ – Middleware integrates blood culture, Gram staining, identification and antimicrobial susceptibility testing results Explore the bioMérieux Integrated Sepsis Solution: https://lnkd.in/eDzufx5B #OptimizeDiagnostics #SepsisManagement *World Health Organization, 2024. Product availability varies by country. Please consult your local bioMérieux representative for product availability in your country.